Synergy Disc Replacement Inc

What Synergy Disc Replacement Inc does

Synergy Spine Solutions Inc., doing business as Synergy Spine Solutions, is a privately held medical device company commercializing the Synergy Disc, an artificial cervical disc replacement indicated for degenerative disc disease at C3-C7. The device is differentiated by a built-in 6-degree lordotic core intended to simultaneously preserve segmental motion and improve sagittal alignment, addressing limitations of both anterior cervical fusion (loss of mobility, adjacent segment disease) and conventional ball-and-socket disc arthroplasty that does not correct alignment. Constructed with nickel-free Ti-6Al-4V titanium alloy endplates, CPTi plasma spray fixation, and an UHMWPE core, the semi-constrained design incorporates a mobile center of rotation, integrated safety stops, a stability zone, and self-biting fins, providing 20-22° flexion-extension ROM, ±12° lateral bending, ±12° axial rotation, and 2mm pure anterior-posterior translation. The technology is protected by more than 55 issued patents worldwide.

The company sells the Synergy Disc to board-certified spine surgeons (orthopedic and neurosurgical) and hospitals on a per-procedure hardware basis. FDA Premarket Approval for 1-level indications at C3-C7 was received in February 2026, supported by an IDE trial demonstrating 87.1% composite clinical success at 24 months versus fusion controls (p<0.0001), with 91.7% NDI improvement vs 75.2%, lower neck pain (15.6 vs 30.2 VAS) and worst arm pain (15.0 vs 32.2) scores, and 84.5% patient satisfaction vs 61.6% in fusion. The first U.S. clinical case using the FDA-approved device was performed in April 2026 by Drs. Lanman and Beckett in Beverly Hills.

Commercially, the device has been available outside the United States for over 10 years across more than 10 countries, with thousands of patients implanted. U.S. commercialization is structured for Spring 2026 launch via a direct field sales organization led by CCO Troy Wahlenmaier and regional VPs Jim Butler (Western U.S.) and Gant Newsom (Eastern U.S.), while international markets are served through exclusive distribution partnerships with Johnson & Johnson MedTech (UK, Ireland, Switzerland, Germany), LifeHealthcare (Australia/New Zealand), Ample Healthcare (Malaysia), and Creatori Health (South Africa). The company is capitalized by a $30 million Series A led by Amzak Health in January 2024 and is conducting a 2-Level IDE trial enrolling 200 patients at 24 U.S. sites.

Name

Synergy Disc Replacement Inc

Legal name

Synergy Spine Solutions Inc.

Website

https://synergyspinesolutions.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

1–10 employees

Short description

Synergy Spine Solutions Inc. is a private medical device company that develops and commercializes the Synergy Disc, an FDA-approved motion-preserving cervical disc replacement designed to restore range of motion and improve spinal alignment for patients with cervical degenerative disc disease.

Ownership category

akta.pro rank

Product category

Spinal Implants - Cervical Disc Replacement

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Spine Implants & Motion Preservation (Fusion/Disc/Interspinous) (HLAHAEAC)

Keywords

• Cervical disc replacement
• Spinal implants
• Motion preservation devices
• Artificial cervical disc
• Spine surgery medical devices

Headquarters

HQ city

Cambridge

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Marketing or Sales, Personnel, Operations, Infrastructure

Revenue model

1. Medical Device Hardware Sales: Synergy Spine Solutions generates revenue through the sale of its Synergy Disc artificial cervical disc implants to hospitals and spine surgeons. The device is commercially available in the United States (following FDA approval in February 2026 for 1-level), Europe, Australia, Canada, South Africa, and Malaysia. Revenue is generated on a per-procedure/per-unit basis as surgeons implant the devices during cervical disc replacement surgeries.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

Core offering

Synergy Spine Solutions develops, manufactures, and sells the Synergy Disc, an FDA-approved (PMA February 2026) motion-preserving artificial cervical disc replacement for the treatment of cervical degenerative disc disease at C3-C7. The device is the first and only cervical disc with a built-in 6-degree lordotic core designed to simultaneously preserve motion and improve sagittal alignment. The product is sold to spine surgeons and hospitals on a per-procedure/per-unit basis through direct enterprise sales in the United States and exclusive distribution partners internationally.

Product overview

Synergy Spine Solutions is a medical device company offering a single flagship product, the Synergy Disc, an FDA-approved artificial cervical disc replacement. The Synergy Disc is the first and only cervical disc designed to improve alignment and provide intentional motion preservation using a unique 6-degree lordotic core with time-tested titanium alloy endplates and UHMWPE polyethylene core. The device is commercially available in the United States (for 1-level indications), Europe, Australia, Canada, South Africa, and Malaysia, with ongoing 2-level IDE clinical trials in the U.S.

Differentiator

Problem solved

Functional benefit

Brands

• Synergy Disc: FDA-approved artificial cervical disc replacement device featuring a built-in 6-degree lordotic core designed to preserve motion and improve sagittal alignment. Made with titanium alloy endplates and ultra-high molecular weight polyethylene (UHMWPE) core.

Products and services

• Synergy Disc FDA-approved motion-preserving artificial cervical disc replacement designed to treat cervical degenerative disc disease at C3-C7. First and only cervical disc with a built-in 6-degree lordotic core designed to both preserve motion and improve sagittal alignment, featuring nickel-free Ti-6Al-4V titanium alloy endplates with CPTi plasma spray fixation, UHMWPE core, semi-constrained design with integrated safety stops, stability zone, and self-biting fins. Sold to spine surgeons and hospitals through direct enterprise sales in the U.S. and exclusive distribution partners internationally.

Quantifiable outcome

• 87.1% composite clinical success at 24 months (p<0.0001 vs fusion)
• +5 more outcomes

Named customers7 records

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Six partnerships are on record, tiered core and major.

• Johnson & Johnson MedTech GermanycoreChannel Partner/ Reseller/ Distributor · 1 October 2025Sales agency agreement expanded to Germany in October 2025. Builds on existing agreements with Johnson & Johnson MedTech in UK, Republic of Ireland, and Switzerland. Represents a key European market for spine innovation.
• Johnson & Johnson MedTech SwitzerlandcoreChannel Partner/ Reseller/ Distributor · 1 April 2025Sales agency agreement expanded to Switzerland effective April 1, 2025. Builds on success of existing agreements in UK and Republic of Ireland. Switzerland is a key European market for spine innovation.
• DePuy Synthes UKcoreChannel Partner/ Reseller/ Distributor · 20 September 2023Multi-year sales agency agreement with DePuy Synthes Spine to expand access to Synergy Disc in the United Kingdom. Combines Synergy's product technology with DePuy's market leadership in spine sales.
• Ample HealthcaremajorChannel Partner/ Reseller/ Distributor · 28 July 2023Exclusive distribution partnership covering Malaysia. Ample Healthcare is based in Kuala Lumpur with focus in spine and orthopaedic surgery. First partner to distribute Synergy Disc in South-East Asia.
• LifeHealthcarecoreChannel Partner/ Reseller/ Distributor · 23 May 2023Exclusive distribution partnership covering Australia and New Zealand. LifeHealthcare is a leading independent medical device distributor under EBOS Medical Technology Division with offices across all major Australian states and New Zealand.
• Creatori HealthmajorChannel Partner/ Reseller/ Distributor · 11 May 2023Exclusive distribution partnership covering South Africa and Namibia. Creatori Health is headquartered in Cape Town with over 15 years of experience distributing specialized spinal implantable devices.

Scale indicators6 records

Recent moves9 records

Expansion highlights5 records

Market position

Competitive moat5 records

Key highlights11 records

Customer concentration

• Xtwitter.com/synergy_spine
• LinkedInlinkedin.com/company/synergy-disc-replacement-inc.
• Instagraminstagram.com/synergy_spine

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds3 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Synergy Disc Replacement Inc